3rd International Conference during October 21-23, 2013 at DoubleTree by Hilton Hotel San Francisco Airport, USA.

LOS ANGELES, CA, USA, August 22, 2013 /EINPresswire.com/ -- Pharmaceutical regulatory affairs play an instrumental role in maintaining the public health by assuring safe and secured healthcare products. It is relatively a new field through which governments are trying to regulate pharmaceuticals, veterinary medicines, medical devices, pesticides, agrochemicals, cosmetics and complementary medicinal industries as there are several legal, ethical, and socioeconomic aspects are involved in the production, distribution and the sales of essential drugs and the other healthcare products.

Governments that have been facing several new and critical challenges in maintaining safe public health are finding ‘Pharmaceutical Regulation’ as an essential tool in assuring quality healthcare products.

OMICS Group 3rd International conference during October 21-23, 2013 at DoubleTree by Hilton Hotel San Francisco Airport, USA assumes significance as it is expected to attract the global regulators, industry professionals, decision makers and academia to engage in systematic analysis on current healthcare regulatory landscape, future advances in scientific research and amendments by regulatory agencies and associations. The conference scientific sessions are specially designed to address the pharmaceutical and biopharmaceutical regulatory requirements, latest trends, and issues globally.

Identification and understanding of regulations and regulatory strategies that may impact the business is the upmost important procedure in today’s economic world. But maintaining the pace with the complex and fast moving changes and alterations in the regulatory requirements is complicated. OMICS Groups regulatory affairs conference thus provides a unique platform for the compliance practitioners to be updated with global changes and strategies in the Pharmaceutical Regulatory Affairs.

Several prominent compliance and regulatory from the Pharmaceutical industry, Government agencies, and academia are expected to attend this conference.

Conference Highlights:
The three days event would highlight the topics like
• Regulatory Affairs for Healthcare Products
• Regulatory Requirements for Pharmaceuticals
• Requirements for Medical Devices
• IND, NDA, BLA, and ANDA
• Biologics and Other Special Categories
• Best Industry Practices
• Business, Law Enforcement, and Education
• Intellectual Property Management
• Novel Strategies for Growth in the Pharma and Regulatory Environment

The 3rd International Conference on Pharmaceutical Regulatory Affairs is to share your views on latest trends and issues in regulatory world.

For more details on Regulatory Affairs-2013 conference, please visit:
http://www.omicsgroup.com/conferences/pharmaceutical-regulatory-affairs-2013/

For further details contact
Kasper Dave
Regulatory Affairs-2013 Organizing Committee
Pharma Conferences
5716 Corsa Ave, Suite110
Westlake, Los Angeles
CA-91362-7354, USA
Office Ph: +1-888-843-8169
Toll No +1-800-216-6499(USA & Canada)
Email: regulatoryaffairs2013@omicsgroup.us
http://www.omicsonline.org/contact.php

Kasper Dave
OMICS Group Incorporation
+1-888-843-8169
email us here

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.